Skip to main content

Table 1 Baseline characteristics at enrolment, by treatment group

From: Efficacy of two artemisinin-based combinations for the treatment of malaria in pregnancy in India: a randomized controlled trial

 

AS+SP (N = 125)

AS+MQ (N = 123)

Total (N = 248)

P-value

Age (years)a

23.1 ± 3.9

23.6 ± 3.7

23.4 ± 3.8

0.2758

Gestation (weeks)a

25.5 ± 6.2

24.8 ± 5.7

25.14 ± 5.95

0.3660

Hb (g/dL)a

8.8 ± 1.1

9.1 ± 1.3

8.96 ± 1.2

0.1126

Asexual parasitaemia/µLa [median (range)]

16,261 ± 30,494 [2800 (32–165,520)]

17,126 ± 30,705 [2220 (32–153,000)]

16,695 ± 30,540 [2400 (32–165,520)]

0.8257

Gametocyte carriage

5 (4.0)

5 (4.1)

10 (4.0)

 

Gravidity

 1

57 (45.6)

52 (42.3)

109 (44.0)

0.5998

 2

37 (29.6)

38 (30.9)

75 (30.2)

0.8253

 3+

31 (24.8)

33 (26.8)

64 (25.8)

0.7163

Parity

 0

64 (51.2)

61 (49.6)

125 (50.4)

0.8012

 1

36 (28.8)

40 (32.5)

76 (30.6)

0.5271

 2+

25 (20.0)

22 (17.9)

47 (19.0)

0.6726

  1. aMean ± SD; percentages in brackets